J&J (NYSE: JNJ) said to offer hip case accord which may exceed $2B
- Wall St. slips on healthcare, consumer names; Fed eyed
- GameStop (GME) Reports In-Line Q2 EPS, Offers Guidance
- St. Jude Medical (STJ) Mentioned as Short at Muddy Waters
- ITT Educational Services (ESI) Shares Decline on Reports of Increased Oversight
- After-Hours Stock Movers 08/25: (EPAY) (PSTG) (OCN) Higher; (TLND) (GME) (SPLK) Lower (more...)
Johnson & Johnson (NYSE: JNJ) said to offer hip case accord which may exceed $2 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Lowers Remicade Outlook for Johnson & Johnson (JNJ); Affirms 'Neutral' Rating
- Elijah Cummings Says Mylan's (MYL) Meager Discount Merely 'PR Move'
- ON Semiconductor (ON) Agrees to Divest IGBT Business as Part of Fairchild Semi (FCS) Acquisition - FTC
Create E-mail Alert Related CategoriesGeneral News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!